Another antibody array study revealed that cyclin D2, cytokeratin 18, cyclin B1, hnRNP m3-m4 and the monophosphorylated ERK were decreased in a doxorubicin resistant breast cancer cell line in comparison to a sensitive one [28]. The gene discussed is CCND2; the disease is breast carcinoma.